Lincus | Home

Creating a Chemical Probe to Identify the Target of a Novel Immune Suppressing Compound

Sponsor: DHHS/NIH/National Institute of Allergy and Infectious Diseases

Authors: Adam Zweifach

Funding: $159,500

2016-12-07 - 2019-11-30

A screening campaign for compounds that prevent cAMP- mediated immunosuppression

Sponsor: DHHS/NIH/National Institutes of Health

Authors: Adam Zweifach

2020-09-01 - 2023-08-31

Screening for glycolysis inhibitors to use as chemical probes

Sponsor: DHHS/NIH/National Institutes of Health

Authors: Adam Zweifach

2018-09-01 - 2022-08-31

A High-throughput Screen of Lytic Granule Exocytosis

Sponsor: DHHS/NIH/National Institute of Neurological Disorders and Stroke

Authors: Adam Zweifach

Funding: $191,250

2010-09-30 - 2014-08-31

Calcium and Cytotoxic T Lymphocytes

Sponsor: DHHS/NIH/National Institute of Allergy and Infectious Diseases

Authors: Adam Zweifach

Funding: $779,455

2006-02-01 - 2010-03-31

Developing a Screening Campaign for Immune Enhancers

Sponsor: DHHS/NIH/National Institute of Allergy and Infectious Diseases

Authors: Adam Zweifach

Funding: $951,192

2016-08-01 - 2021-07-31

A High-throughput Screen of Lytic Granule Exocytosis

Sponsor: DHHS/NIH/National Institute of Neurological Disorders and Stroke

Authors: Adam Zweifach

2009-04-01 - 2011-03-31

Analogs of a Novel Immunosuppressive Compound

Sponsor: DHHS/NIH/National Institutes of Health

Authors: Adam Zweifach

2016-09-01 - 2018-08-31

A High-throughput Screen of Lytic Granule Exocytosis

Sponsor: DHHS/NIH/National Institute of Neurological Disorders and Stroke

Authors: Adam Zweifach

2010-07-01 - 2012-06-30

Statistical Analysis Of High-Throughput Screening

Sponsor: DHHS/NIH/National Institutes of Health

Authors: Adam Zweifach

2022-07-01 - 2026-06-30

Genome-wide screening for proteins involved in cAMP-mediated immunosuppression

Sponsor: DHHS/NIH/National Institutes of Health

Authors: Adam Zweifach

2023-04-01 - 2025-03-31

Inhibitors of Hexokinase 2

Sponsor: Connecticut Innovations/Yale University

Authors: Adam Zweifach

Funding: $10,000

2017-09-01 - 2018-12-17

Developing a High-Throughput Screen for Cytotoxic T Cell Lytic Granule Exocytosis

Sponsor: DHHS/NIH/National Institutes of Health

Authors: Adam Zweifach

2008-12-01 - 2010-11-30

High Throughput Screening for Small-Molecule Immune Adjuvants for Cancer Therapy

Sponsor: DHHS/NIH/National Cancer Institute

Authors: Adam Zweifach

2014-07-01 - 2017-06-30

Identifying the Cellular Targets of Novel Compounds that Inhibit T Cell Activation

Sponsor: DHHS/NIH/National Institutes of Health

Authors: Adam Zweifach

2017-04-01 - 2019-03-31

Novel Immune Modulating Compounds from Tunicate-Associated Bacteria

Sponsor: DHHS/NIH/National Institutes of Health

Authors: Adam Zweifach

2015-07-01 - 2017-06-30

Preteomics and CTL Granule Exocytosis

Sponsor: DHHS/NIH/National Institutes of Health

Authors: Adam Zweifach

2009-04-01 - 2011-03-31

Developing Chemical Probes to Study the Relationship Between Glycolysis and Cancer Cell Proliferation

Sponsor: DHHS/NIH/National Institutes of Health

Authors: Adam Zweifach

2018-05-01 - 2020-04-30

Developing a Multiplexed Cytometric Cell-Based FRET Assay for Compounds that Activate C1 Domain Proteins

Sponsor: DHHS/NIH/National Institutes of Health

Authors: Adam Zweifach

2017-04-01 - 2020-03-31

Analogs of a Novel Immunosuppressive Compound

Sponsor: DHHS/NIH/National Institutes of Health

Authors: Adam Zweifach

2015-09-01 - 2017-08-31

Are you Adam Zweifach?

How to update your information.